Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3)

The overall goal of this initiative is to identify neurophysiological measures as potential assays for treatment development research. The objectives of this grant will be accomplished by supporting partnerships among basic and translational neuroscientists who are committed to advancing the discovery of in vivo physiological measures as tools for target validation and therapeutic development. 

Funding: No fixed limit 

Duration: 5 years total 

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates: 20.5.19, 18.9.19, 20.1.20, 19.5.20, 20.9.20, 19.1.21, 21.5.21, 20.9.21

Full proposal due dates: 20.6.19, 18.10.19, 20.2.20, 19.6.20, 20.10.20, 19.2.21, 21.6.21, 20.10.21